HIV

Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
digital pills
HIV
PrEP
Gilead Sciences
Merck pauses 2 more trials of backbone HIV drug over red flag, raising doubts about multipronged R&D strategy
Fierce Biotech
Tue, 12/7/21 - 10:43 am
Merck
HIV
clinical trials
MK-8507
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms
Fierce Pharma
Tue, 11/30/21 - 11:24 pm
ViiV Healthcare
GSK
HIV
PrEP
cabotegravir
Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo
Fierce Biotech
Fri, 11/19/21 - 10:54 am
Merck
HIV
MK-8507
clinical trials
Exavir Aims CRISPR Program at HIV, Sees Powerful Preclinical Results
BioSpace
Wed, 11/10/21 - 10:47 am
HIV
Exavir Therapeutics
gene editing
CRISPR
GSK's ViiV turns to Black women's experiences in latest season of award-winning podcast
Fierce Pharma
Tue, 11/9/21 - 10:35 am
GSK
ViiV Healthcare
HIV
AIDS
podcasts
pharma marketing
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Gilead Sciences
Biktarvy
HIV
RWE
Merck's experimental HIV drug islatravir hits with a PhIII combo win and FDA filing plans
Endpoints
Mon, 10/25/21 - 11:07 am
Merck
HIV
islatravir
clinical trials
Janssen, Brickell and ViiV are Knocking on FDA's Door
BioSpace
Sat, 10/9/21 - 10:56 pm
FDA
Janssen
Stelara
juvenile psoriatic arthritis
Brickell Bio
sofpironium bromide gel
ViiV Healthcare
HIV
Triumeq
Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
Endpoints
Wed, 09/29/21 - 11:01 am
Gilead Sciences
Teva Pharmaceutical
Bristol Myers Squibb
CVS
Rite Aid
generics
HIV
FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure
BioSpace
Thu, 09/16/21 - 10:36 pm
FDA
CRISPR
HIV
EBT-101
Excision BioTherapeutics
clinical trials
FDA clears first-of-its-kind trial to see if CRISPR gene editing can cure HIV
Endpoints
Wed, 09/15/21 - 10:26 pm
Excision BioTherapeutics
CRISPR
clinical trials
HIV
gene editing
Johnson & Johnson’s HIV vaccine fails first efficacy trial
Stat
Tue, 08/31/21 - 12:35 pm
HIV
vaccines
JNJ
clinical trials
Could Moderna Take Down Gilead Sciences?
Motley Fool
Mon, 08/30/21 - 10:52 am
Moderna Therapeutics
HIV
vaccines
MRNA
Gilead Sciences
Moderna to Launch Clinical Trials for mRNA-Based HIV Vaccine
BioSpace
Tue, 08/17/21 - 10:50 pm
Moderna Therapeutics
clinical trials
HIV
vaccines
MRNA
Gilead cements its long-acting HIV ambitions
EP Vantage
Fri, 08/13/21 - 10:51 am
Gilead Sciences
HIV
lenacapavir
clinical trials
Mid-Study Peek at Merck's Once-A-Month HIV Preventative Shows Promise
BioSpace
Tue, 07/20/21 - 11:45 pm
Merck
HIV
clinical trials
islatravir
PrEP
Gilead challenges ViiV in resistant HIV, filing twice-yearly therapy
Pharmaforum
Tue, 06/29/21 - 10:52 am
Gilead Sciences
HIV
ViiV Healthcare
FDA
lenacapavir
Rukobia
Langer lab spinout Lyndra raises $60.5M in bid to replace existing HIV, schizophrenia, opioid abuse treatments
Endpoints
Thu, 06/24/21 - 11:10 am
Langer
Lyndra
funding
HIV
schizophrenia
opioid abuse
Glaxo needs long-acting HIV gamble to pay off
EP Vantage
Thu, 06/24/21 - 10:57 am
GSK
HIV
Dolutegravir
patents

Pages